Opportunities

Opportunities

Renforcement des capacités

Candidatures fermées

MCE Mini MBA for the Pharmaceutical and Biotech Industry

Organisation: Management Centre Europe (MCE)
Application deadline: 1 mars 2026
Format: Hybridee
Localisation: Pays-Bas (Royaume des)
Start Date: 2 mars 2026
Duration: 3 semaines

À propos

Understand how the pharmaceutical and biotech industries operate today and develop the essential management skills needed to accelerate your career.

In today’s pharmaceutical environment, technical expertise alone is no longer sufficient. Digital transformation, rising patient expectations, regulatory complexity, and fast-changing market dynamics require professionals to think strategically, collaborate across functions, and lead effectively through uncertainty. Success increasingly depends on connecting functional expertise to the broader business context.

The Mini MBA for the Pharmaceutical and Biotech Industries is a high-impact, intensive programme designed for professionals with specialist backgrounds, such as Market Access, Medical Affairs, Operations, R&D, Finance, Sales, or Marketing, who are transitioning into management or leadership roles.

Who This Programme is For

This programme is ideal for pharmaceutical and biotech professionals who:

  • Have a technical or specialist background
  • Are managing increased complexity and broader responsibilities
  • Need to influence across functions and stakeholders
  • Want to strengthen their financial, strategic, and leadership capabilities
  • Aim to motivate teams while aligning science, operations, and commercial goals

The Mini MBA equips participants with the tools, skills, and behaviours required to perform effectively as managers and leaders in the life sciences sector.

Key Competencies Developed

  • Strategic and integrated business thinking
  • Leadership and people management
  • Financial fluency for non-financial managers
  • Innovation and agility
  • Cross-functional collaboration and impact
  • GenAI for strategic decision-making

Programme Highlights

  • Lead diverse teams confidently through change and complexity
  • Bridge the gap between technical excellence and business impact
  • Gain a holistic view of the pharmaceutical value chain, from R&D to market access

What You Will Learn

Participants will:

  • Understand the full pharmaceutical landscape, including market trends, financial dynamics, patient value, and digital transformation
  • Strengthen cross-functional collaboration between commercial, medical, and operational teams
  • Apply design thinking and agile approaches to real-world pharma challenges
  • Use GenAI tools to enhance strategy, decision-making, and business model innovation
  • Analyse complex business challenges using strategic frameworks and financial models
  • Navigate regulatory, market access, and stakeholder complexities
  • Inspire and lead teams in a rapidly evolving healthcare environment

Programme Structure

The Mini MBA is delivered as a highly interactive, hands-on learning experience, combining practical exercises, role plays, and real-life industry cases. It is facilitated by senior experts with extensive management experience in international life sciences organisations.

Core Modules

  1. Strategic Fundamentals in Pharma
  2. Leading People and Driving Change
  3. Innovation, Digital Transformation, and Patient-Centricity
  4. Financial Acumen for Strategic Decision-Making
  5. Integrated Execution and GenAI for Strategic Impact

Learning Formats

The programme is available in multiple learning formats, including face-to-face, live online, and tailored in-company solutions for teams.

The face-to-face training will be delivered across multiple cities in the Netherlands, the UAE, Switzerland, and Austria.

Fees

  • Face-to-face (5 days): €4,295
  • Live online (12 sessions): €4,295
  • In Company: The programme is available as an In-Company solutions

Groupe cible

Société civile

Site web

https://mce.eu/programmes/mini-mba-for-the-pharmaceutical-and-biotech-industries/?_gl=1*1rglhxs*_up*MQ..*_ga*MjgyNDg0OTc2LjE3NzAwMzExMzg.*_ga_8CMP6VJW37*czE3NzAwMzExMzckbzEkZzAkdDE3NzAwMzExMzckajYwJGwwJGgw
Financement

Ce projet est financé par l'Union Européenne. Les points de vue exprimés dans ce document sont ceux de l'auteur (ou des auteurs) et ne reflètent pas nécessairement ceux de l'Union Européenne ou de l'Agence Exécutive pour l'Innovation et les PME (EISMEA). Ni l'Union Européenne ni l'entité octroyant la subvention ne peuvent être tenues responsables.